The global sacroiliac joint fusion injections and RF ablation market size is expected to reach USD 1.51 billion by 2030, expanding at a CAGR of 20.2% from 2024 to 2030. Key market players are investing substantially in research & development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements. ![Global Sacroiliac Joint Fusion Injections and RF Ablation Market]( "Global Sacroiliac Joint Fusion Injections and RF Ablation Market")
Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. According to the National Center for Biotechnology Information (NCBI) study published in December 2023, approximately 23% of adults globally experience chronic low back pain, and the recurrence rate within a year range from 24% to 80%. The lifetime back pain prevalence in adults reaches as high as 84%.
This product will be delivered within 1-3 business days.
Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. According to the National Center for Biotechnology Information (NCBI) study published in December 2023, approximately 23% of adults globally experience chronic low back pain, and the recurrence rate within a year range from 24% to 80%. The lifetime back pain prevalence in adults reaches as high as 84%.
Sacroiliac Joint Fusion Injections and RF Ablation Market Report Highlights
- Based on indication, thedegenerative sacroilitis segment accounted for the largest revenue share in 2023 and is anticipated to grow at the fastest CAGR. The growth is attributed to the growing awareness about the condition, improving diagnostic capabilities for sacroiliac joint disorders, and a high prevalence of degenerative sacroiliitis
- Based on type, the diagnosis segment accounted for the largest market share in 2023. The growth is attributed to the accurate diagnosis and determining the appropriate treatment for sacroiliac joint pain
- Based on end-use, the hospitals segment accounted for the largest revenue share in 2023 owing to the higher volume of surgeries performed in hospitals and a growing preference for minimally invasive surgeries
- In 2023, North America dominated the overall market with a revenue share of 41.1% owing to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Indication
1.2.2. Type
1.2.3. End-use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Indication
1.2.2. Type
1.2.3. End-use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Indication outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.3. Regional outlook
2.4. Competitive Insights
2.2. Segment Outlook
2.2.1. Indication outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Sacroiliac Joint Fusion Injections and RF Ablation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Sacroiliac Joint Fusion Injections and RF Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Sacroiliac Joint Fusion Injections and RF Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Sacroiliac Joint Fusion Injections and RF Ablation Market: Indication Estimates & Trend Analysis
4.1. Indication Segment Dashboard
4.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: Indication Movement Analysis
4.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by Indication Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Degenerative Sacroilitis
4.5.1. Degenerative Sacroilitis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Sacral Disruption
4.6.1. Sacral Disruption Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Trauma
4.7.1. Trauma Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: Indication Movement Analysis
4.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by Indication Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Degenerative Sacroilitis
4.5.1. Degenerative Sacroilitis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Sacral Disruption
4.6.1. Sacral Disruption Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Trauma
4.7.1. Trauma Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Sacroiliac Joint Fusion Injections and RF Ablation Market: Type Estimates & Trend Analysis
5.1. Type Segment Dashboard
5.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: Type Movement Analysis
5.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Diagnosis
5.5.1. Diagnosis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Treatment
5.6.1. Treatment Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: Type Movement Analysis
5.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Diagnosis
5.5.1. Diagnosis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Treatment
5.6.1. Treatment Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Sacroiliac Joint Fusion Injections and RF Ablation Market: End-use Estimates & Trend Analysis
6.1. End-use Segment Dashboard
6.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: End-use Movement Analysis
6.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by End-use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Ambulatory Surgical Centers
6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: End-use Movement Analysis
6.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by End-use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Ambulatory Surgical Centers
6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Sacroiliac Joint Fusion Injections and RF Ablation Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Sacroiliac Joint Fusion Injections and RF Ablation Market Movement analysis
7.3. Sacroiliac Joint Fusion Injections and RF Ablation Market: Regional Estimates & Trend Analysis by Indication, Type & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. U.S. Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Mexico Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.4. Canada
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Canada Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. UK Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Germany Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. France Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Italy Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Spain Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Denmark Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Sweden Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Norway Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. South Korea Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Australia Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Thailand Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.2. Regional Sacroiliac Joint Fusion Injections and RF Ablation Market Movement analysis
7.3. Sacroiliac Joint Fusion Injections and RF Ablation Market: Regional Estimates & Trend Analysis by Indication, Type & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. U.S. Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Mexico Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.4. Canada
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Canada Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. UK Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Germany Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. France Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Italy Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Spain Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Denmark Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Sweden Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Norway Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. South Korea Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Australia Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Thailand Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. SI-BONE, Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. PainTEQ
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. CornerLoc
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. SIGNUS Medizintechnik GmbH
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Globus Medical
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Orthofix Medical, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Life Spine, Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Camber Spine Technologies, LLC
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. CoreLink Surgical
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Xtant Medical
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Surgalign Spine Technologies, Inc.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Medtronic
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2. Key Company Profiles
8.2.1. SI-BONE, Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. PainTEQ
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. CornerLoc
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. SIGNUS Medizintechnik GmbH
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Globus Medical
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Orthofix Medical, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Life Spine, Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Camber Spine Technologies, LLC
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. CoreLink Surgical
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Xtant Medical
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Surgalign Spine Technologies, Inc.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Medtronic
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 4 Global Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 5 Global Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 6 North America Sacroiliac joint fusion injections and RF ablation market, by region, 2018-2030 (USD Million)
Table 7 North America Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 8 North America Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 9 North America Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 10 U.S. Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 11 U.S. Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 12 U.S. Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 13 Canada Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 14 Canada Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 15 Canada Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 16 Mexico Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 17 Mexico Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 18 Mexico Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 19 Europe Sacroiliac joint fusion injections and RF ablation market, by country, 2018-2030 (USD Million)
Table 20 Europe Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 21 Europe Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 22 Europe Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 23 UK Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 24 UK Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 25 UK Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 26 Germany Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 27 Germany Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 28 Germany Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 29 France Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 30 France Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 31 France Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 32 Italy Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 33 Italy Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 34 Italy Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 35 Spain Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 36 Spain Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 37 Spain Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 38 Norway Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 39 Norway Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 40 Norway Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 41 Sweden Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 42 Sweden Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 43 Sweden Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 44 Denmark Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 45 Denmark Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 46 Denmark Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 47 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by country, 2018-2030 (USD Million)
Table 48 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 49 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 50 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 51 Japan Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 52 Japan Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 53 Japan Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 54 China Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 55 China Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 56 China Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 57 India Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 58 India Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 59 India Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 60 Australia Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 61 Australia Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 62 Australia Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 63 South Korea Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 64 South Korea Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 65 South Korea Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 66 Thailand Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 67 Thailand Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 68 Thailand Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 69 Latin America Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 70 Latin America Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 71 Latin America Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 72 Brazil Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 73 Brazil Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 74 Brazil Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 75 Argentina Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 76 Argentina Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 77 Argentina Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 78 Middle East & Africa Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 79 Middle East & Africa Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 80 Middle East & Africa Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 81 South Africa Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 82 South Africa Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 83 South Africa Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 84 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 85 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 86 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 87 UAE Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 88 UAE Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 89 UAE Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 90 Kuwait Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 91 Kuwait Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 92 Kuwait Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Global Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 4 Global Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 5 Global Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 6 North America Sacroiliac joint fusion injections and RF ablation market, by region, 2018-2030 (USD Million)
Table 7 North America Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 8 North America Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 9 North America Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 10 U.S. Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 11 U.S. Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 12 U.S. Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 13 Canada Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 14 Canada Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 15 Canada Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 16 Mexico Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 17 Mexico Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 18 Mexico Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 19 Europe Sacroiliac joint fusion injections and RF ablation market, by country, 2018-2030 (USD Million)
Table 20 Europe Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 21 Europe Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 22 Europe Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 23 UK Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 24 UK Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 25 UK Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 26 Germany Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 27 Germany Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 28 Germany Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 29 France Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 30 France Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 31 France Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 32 Italy Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 33 Italy Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 34 Italy Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 35 Spain Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 36 Spain Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 37 Spain Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 38 Norway Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 39 Norway Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 40 Norway Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 41 Sweden Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 42 Sweden Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 43 Sweden Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 44 Denmark Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 45 Denmark Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 46 Denmark Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 47 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by country, 2018-2030 (USD Million)
Table 48 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 49 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 50 Asia Pacific Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 51 Japan Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 52 Japan Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 53 Japan Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 54 China Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 55 China Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 56 China Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 57 India Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 58 India Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 59 India Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 60 Australia Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 61 Australia Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 62 Australia Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 63 South Korea Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 64 South Korea Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 65 South Korea Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 66 Thailand Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 67 Thailand Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 68 Thailand Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 69 Latin America Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 70 Latin America Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 71 Latin America Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 72 Brazil Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 73 Brazil Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 74 Brazil Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 75 Argentina Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 76 Argentina Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 77 Argentina Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 78 Middle East & Africa Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 79 Middle East & Africa Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 80 Middle East & Africa Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 81 South Africa Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 82 South Africa Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 83 South Africa Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 84 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 85 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 86 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 87 UAE Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 88 UAE Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 89 UAE Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
Table 90 Kuwait Sacroiliac joint fusion injections and RF ablation market, by indication, 2018-2030 (USD Million)
Table 91 Kuwait Sacroiliac joint fusion injections and RF ablation market, by type, 2018-2030 (USD Million)
Table 92 Kuwait Sacroiliac joint fusion injections and RF ablation market, by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Sacroiliac joint fusion injections and RF ablation market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Sacroiliac joint fusion injections and RF ablation market, indication outlook key takeaways (USD Million)
Figure 12 Sacroiliac joint fusion injections and RF ablation market: indication movement analysis 2023 & 2030 (USD Million)
Figure 13 Degenerative Sacroilitis market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 14 Sacral Disruption market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 15 Trauma market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 16 Sacroiliac joint fusion injections and RF ablation market, type outlook key takeaways (USD Million)
Figure 17 Sacroiliac joint fusion injections and RF ablation market: type movement analysis 2023 & 2030 (USD Million)
Figure 18 Diagnosis market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 19 Treatment market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Sacroiliac joint fusion injections and RF ablation market, end-use outlook key takeaways (USD Million)
Figure 21 Sacroiliac joint fusion injections and RF ablation market: end-use movement analysis 2023 & 2030 (USD Million)
Figure 22 Hospitals market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Ambulatory Surgical Centers market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Others market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Sacroiliac joint fusion injections and RF ablation market: Regional key takeaways (USD Million)
Figure 26 Sacroiliac joint fusion injections and RF ablation market: regional outlook, 2023 & 2030, USD Million
Figure 27 North America Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 U.S. Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Canada Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Mexico Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Europe Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 UK Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Germany Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 France Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Spain Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Norway Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Sweden Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Denmark Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Asia Pacific Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 China Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Japan Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 India Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 South Korea Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Australia Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Thailand Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Latin America Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Brazil Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Argentina Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Middle East and Africa Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 South Africa Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 UAE Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Kuwait Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Key company categorization
Figure 55 Heat map analysis, 2022-2023
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Sacroiliac joint fusion injections and RF ablation market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Sacroiliac joint fusion injections and RF ablation market, indication outlook key takeaways (USD Million)
Figure 12 Sacroiliac joint fusion injections and RF ablation market: indication movement analysis 2023 & 2030 (USD Million)
Figure 13 Degenerative Sacroilitis market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 14 Sacral Disruption market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 15 Trauma market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 16 Sacroiliac joint fusion injections and RF ablation market, type outlook key takeaways (USD Million)
Figure 17 Sacroiliac joint fusion injections and RF ablation market: type movement analysis 2023 & 2030 (USD Million)
Figure 18 Diagnosis market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 19 Treatment market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Sacroiliac joint fusion injections and RF ablation market, end-use outlook key takeaways (USD Million)
Figure 21 Sacroiliac joint fusion injections and RF ablation market: end-use movement analysis 2023 & 2030 (USD Million)
Figure 22 Hospitals market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Ambulatory Surgical Centers market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Others market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Sacroiliac joint fusion injections and RF ablation market: Regional key takeaways (USD Million)
Figure 26 Sacroiliac joint fusion injections and RF ablation market: regional outlook, 2023 & 2030, USD Million
Figure 27 North America Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 U.S. Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Canada Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Mexico Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Europe Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 UK Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Germany Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 France Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Spain Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Norway Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Sweden Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Denmark Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Asia Pacific Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 China Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Japan Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 India Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 South Korea Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Australia Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Thailand Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Latin America Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Brazil Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Argentina Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Middle East and Africa Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 South Africa Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Saudi Arabia Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 UAE Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Kuwait Sacroiliac joint fusion injections and RF ablation market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Key company categorization
Figure 55 Heat map analysis, 2022-2023
Companies Mentioned
- SI-BONE, Inc.
- PainTEQ
- CornerLoc
- SIGNUS Medizintechnik GmbH
- Globus Medical
- Orthofix Medical, Inc.
- Life Spine, Inc.
- Camber Spine Technologies, LLC
- CoreLink Surgical
- Xtant Medical
- Surgalign Spine Technologies, Inc.
- Medtronic
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 427.4 Million |
| Forecasted Market Value ( USD | $ 1510 Million |
| Compound Annual Growth Rate | 20.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
